Evidence map›Paper›PMID 41516299›Full record

ArticleInternational journal of molecular sciences2025

Congenital Viral Infection Risk: The Role of Parvovirus B19 and Cytomegalovirus Molecular Genetic Testing.

Stefka Krumova, Ivelina Trifonova, Mariela Hristova-Savova, Lora Veleva, Radostina Stefanova, Petia Genova-Kalou, Petya Chaveeva, Vasil Kalev, Tanya Tilkova, Tsvetoslav Vassilev and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stefka KrumovaNational Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.ORCID 0000-0001-6941-0989
Ivelina TrifonovaNational Reference Laboratory "NRL of Influenza and Acute Respiratory Diseases", Department of Virology, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.ORCID 0000-0002-4543-6831
Mariela Hristova-SavovaNational Reference Laboratory "Herpes and Oncogenic Viruses", Department of Virology, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.ORCID 0000-0001-9048-4288
Lora VelevaNational Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.
Radostina StefanovaNational Reference Laboratory "Measles, Mumps, Rubella", Department of Virology, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.
Petia Genova-KalouNational Reference Laboratory "Cell Cultures and Rickettsia", Department of Virology, National Center of Infectious and Parasitic Diseases, 1000 Sofia, Bulgaria.ORCID 0000-0003-3820-3658
Petya ChaveevaMedical Complex "Dr. Shterev", 1000 Sofia, Bulgaria.ORCID 0000-0002-8041-2181
Vasil KalevMedical Complex "Dr. Shterev", 1000 Sofia, Bulgaria.
Tanya TilkovaMedical Complex "Dr. Shterev", 1000 Sofia, Bulgaria.
Tsvetoslav VassilevMedical Complex "Dr. Shterev", 1000 Sofia, Bulgaria.
Ivanka DimovaMedical Complex "Dr. Shterev", 1000 Sofia, Bulgaria.

Funding

Programme "Research, Innovation and Digitalization for Smart Transformation 2021 - 2027" "Contract BG16RFPR002-1.014-0017 "Center of Competence ImmunoPathogen", proce-dure BG16RFPR002-1.014 " Sustainable development of Centers of Excellence and Centers of Competence, including specific infrastructures or their associations of the NRRI "
6 · The paper itself

Abstract

Parvovirus B19 and cytomegalovirus are significant causes of congenital infections that can lead to adverse pregnancy outcomes. The present study aimed to investigate the infection of B19V and CMV in pregnant women with fetal anemia, effusions and intrauterine growth restriction and determine the utility of routine laboratory screening in pregnancy follow-up. Thirteen women with such pathological pregnancy complications attending an antenatal clinic from April 2024 to March 2025 were tested. Three types of clinical material were examined: maternal blood, amniotic fluid and umbilical cord serum. Participants underwent molecular and serological testing for both B19V and CMV. Demographic data, obstetric histories, and pregnancy outcomes were recorded and analyzed. Our results indicate that three participants showed evidence of either current infection with CMV and seven with B19V. Pregnant women with active infections required further follow-up and fetal surveillance. A stillbirth was reported in one woman with CMV infection. For seven samples that tested positive for B19V DNA, viral sequences were obtained and clustered with genotype 1a reference strains. The findings of this study highlight the significant contribution of B19V and CMV infections during pregnancy, particularly in cases complicated by fetal anemia, effusions, and intrauterine growth restriction.

Indexed as

CytomegalovirusCytomegalovirus InfectionsParvoviridae InfectionsParvovirus B19, HumanPregnancy Complications, InfectiousAdultDNA, ViralFemaleGenetic TestingHumansPregnancyDNA, Viralantenatal screeningB19VCMVcongenital infectionpregnancy

Identifiers

PMID41516299
PMCPMC12786935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.